Blackstone Inc’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,000	Closed	-$66K	–	107
2019 Q2	$66K	Buy	+5,000	New	+$66K	﹤0.01%	82